Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 1.18
IVC's Cash to Debt is ranked higher than
65% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. IVC: 1.18 )
IVC' s 10-Year Cash to Debt Range
Min: 0   Max: 1.18
Current: 1.18

0
1.18
Equity to Asset 0.59
IVC's Equity to Asset is ranked higher than
67% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. IVC: 0.59 )
IVC' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.61
Current: 0.59

0.32
0.61
F-Score: 4
Z-Score: 2.49
M-Score: -2.79
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -3.97
IVC's Operating margin (%) is ranked higher than
63% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. IVC: -3.97 )
IVC' s 10-Year Operating margin (%) Range
Min: -2.6   Max: 10.8
Current: -3.97

-2.6
10.8
Net-margin (%) -4.01
IVC's Net-margin (%) is ranked higher than
63% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. IVC: -4.01 )
IVC' s 10-Year Net-margin (%) Range
Min: -21.21   Max: 6.42
Current: -4.01

-21.21
6.42
ROE (%) -8.08
IVC's ROE (%) is ranked higher than
61% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. IVC: -8.08 )
IVC' s 10-Year ROE (%) Range
Min: -51.33   Max: 17.92
Current: -8.08

-51.33
17.92
ROA (%) -4.87
IVC's ROA (%) is ranked higher than
63% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. IVC: -4.87 )
IVC' s 10-Year ROA (%) Range
Min: -20.26   Max: 8.63
Current: -4.87

-20.26
8.63
ROC (Joel Greenblatt) (%) -23.17
IVC's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. IVC: -23.17 )
IVC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -12   Max: 59.67
Current: -23.17

-12
59.67
Revenue Growth (3Y)(%) -1.10
IVC's Revenue Growth (3Y)(%) is ranked higher than
65% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. IVC: -1.10 )
IVC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -5.5   Max: 17.3
Current: -1.1

-5.5
17.3
EBITDA Growth (3Y)(%) -71.50
IVC's EBITDA Growth (3Y)(%) is ranked higher than
51% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. IVC: -71.50 )
IVC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -71.5   Max: 82.8
Current: -71.5

-71.5
82.8
» IVC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

IVC Guru Trades in Q4 2013

Jim Simons 393,300 sh (+26.18%)
Chuck Royce 1,455,761 sh (+9.11%)
Richard Snow 56,925 sh (-45.31%)
» More
Q1 2014

IVC Guru Trades in Q1 2014

Paul Tudor Jones 12,300 sh (New)
Richard Snow Sold Out
Chuck Royce 1,329,161 sh (-8.7%)
Jim Simons 243,693 sh (-38.04%)
» More
Q2 2014

IVC Guru Trades in Q2 2014

HOTCHKIS & WILEY 1,243,400 sh (New)
Chuck Royce 1,689,436 sh (+27.11%)
Paul Tudor Jones Sold Out
Jim Simons 87,000 sh (-64.3%)
» More
Q3 2014

IVC Guru Trades in Q3 2014

HOTCHKIS & WILEY 2,173,400 sh (+74.79%)
Jim Simons Sold Out
Chuck Royce 1,680,036 sh (-0.56%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
HOTCHKIS & WILEY 2014-09-30 Add 74.79%0.04%$12.29 - $18.78 $ 16.629%2173400
HOTCHKIS & WILEY 2014-06-30 New Buy0.08%$15.8 - $19.71 $ 16.62-2%1243400
Richard Snow 2014-03-31 Sold Out 0.08%$18.47 - $25.3 $ 16.62-20%0
Richard Snow 2013-12-31 Reduce -45.31%0.04%$16.54 - $23.09 $ 16.62-20%56925
Richard Snow 2013-09-30 Add 25.7%0.02%$14.53 - $17.46 $ 16.625%104095
Joel Greenblatt 2013-06-30 Sold Out 0.04%$11.11 - $16.23 $ 16.6220%0
Joel Greenblatt 2013-03-31 New Buy0.04%$12.84 - $17.18 $ 16.628%66151
Richard Snow 2013-03-31 Add 55.55%0.02%$12.84 - $17.18 $ 16.628%83870
Richard Snow 2012-12-31 Add 97.33%0.02%$12.98 - $16.45 $ 16.6216%53920
Joel Greenblatt 2012-06-30 Sold Out 0.08%$14.2 - $16.46 $ 16.629%0
Richard Snow 2012-06-30 New Buy0.02%$14.2 - $16.46 $ 16.629%25325
Joel Greenblatt 2012-03-31 New Buy0.08%$15.49 - $17.94 $ 16.626%54104
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.88
IVC's P/B is ranked higher than
96% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. IVC: 0.88 )
IVC' s 10-Year P/B Range
Min: 0.55   Max: 2.36
Current: 0.88

0.55
2.36
P/S 0.41
IVC's P/S is ranked higher than
96% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. IVC: 0.41 )
IVC' s 10-Year P/S Range
Min: 0.26   Max: 1.21
Current: 0.41

0.26
1.21
Shiller P/E 45.42
IVC's Shiller P/E is ranked higher than
87% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. IVC: 45.42 )
IVC' s 10-Year Shiller P/E Range
Min: 10.78   Max: 44.92
Current: 45.42

10.78
44.92
Current Ratio 1.40
IVC's Current Ratio is ranked higher than
52% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. IVC: 1.40 )
IVC' s 10-Year Current Ratio Range
Min: 1.4   Max: 2.75
Current: 1.4

1.4
2.75
Quick Ratio 0.84
IVC's Quick Ratio is ranked higher than
50% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. IVC: 0.84 )
IVC' s 10-Year Quick Ratio Range
Min: 0.84   Max: 1.99
Current: 0.84

0.84
1.99

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.30
IVC's Dividend Yield is ranked lower than
89% of the 185 Companies
in the Global Medical Devices industry.

( Industry Median: 1.35 vs. IVC: 0.30 )
IVC' s 10-Year Dividend Yield Range
Min: 0.1   Max: 0.46
Current: 0.3

0.1
0.46
Yield on cost (5-Year) 0.30
IVC's Yield on cost (5-Year) is ranked lower than
89% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. IVC: 0.30 )
IVC' s 10-Year Yield on cost (5-Year) Range
Min: 0.1   Max: 0.46
Current: 0.3

0.1
0.46
Share Buyback Rate 0.70
IVC's Share Buyback Rate is ranked higher than
91% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. IVC: 0.70 )
IVC' s 10-Year Share Buyback Rate Range
Min: 1.3   Max: -2.6
Current: 0.7

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.69
IVC's Price/Tangible Book is ranked higher than
76% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. IVC: 4.69 )
IVC' s 10-Year Price/Tangible Book Range
Min: 3.31   Max: 94.61
Current: 4.69

3.31
94.61
Price/DCF (Projected) 0.47
IVC's Price/DCF (Projected) is ranked higher than
99% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. IVC: 0.47 )
IVC' s 10-Year Price/DCF (Projected) Range
Min: 0.33   Max: 3.85
Current: 0.47

0.33
3.85
Price/Median PS Value 0.87
IVC's Price/Median PS Value is ranked higher than
86% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. IVC: 0.87 )
IVC' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 3.42
Current: 0.87

0.6
3.42
Earnings Yield (Greenblatt) -9.80
IVC's Earnings Yield (Greenblatt) is ranked higher than
54% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. IVC: -9.80 )
IVC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 10.8
Current: -9.8

0.1
10.8
Forward Rate of Return (Yacktman) -19.49
IVC's Forward Rate of Return (Yacktman) is ranked higher than
59% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.52 vs. IVC: -19.49 )
IVC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -19.1   Max: 20.4
Current: -19.49

-19.1
20.4

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:IV3.Germany,
Invacare Corp was incorporated in 1971. The Company manufactures and distributes in various markets for medical equipment used in the home and long-term care settings based upon its distribution channels, breadth of product line and net sales. It also designs, manufactures and distributes an extensive line of health care products for the non-acute care environment, including the home health care and extended care markets. The Company sells its products to home health care and medical equipment providers, distributors and government locations in the United States, Europe, Canada, New Zealand, Australia and Asia. Its products are sold through the distribution network by its sales force, telesales associates and independent manufacturers' representatives and distributors. The Company operates in four primary business segments; North America/Home Medical Equipment or North America/HME, Institutional Products Group (IPG), Europe and Asia/Pacific. The North America/HME segment sells each of three primary product lines, which includes; lifestyle, mobility and seating and respiratory therapy products. IPG sells or rents long-term care medical equipment, health care furnishings and accessory products. Europe and Asia/Pacific sell product lines similar to North America/HME and IPG. Each business segment sells to the home health care, retail and extended care markets. The Company purchases raw materials, fabricated components, some finished goods and services from a variety of suppliers. Raw materials such as plastics, steel and aluminum are considered key raw materials. The Company's North America/HME sales and marketing organization consists primarily of a sales force which markets and sells Invacare branded products to HME providers. It also holds patent and other intellectual property licenses from third parties for some of its products and on technologies that are necessary in the design and manufacture of some of the Company's products. The Company is directly affected by government regulation and reimbursement policies in virtually every country in which the Company operates.
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 
Invacare Corporation Reports Earnings within Guidance and Strong Free Cash Flow Jan 29 2009 
Invacare Corporation to Host Conference Call to Discuss Q4 2008 Results Jan 20 2009 
Weekly CEO Buys Highlight: American Water Works Company, Inc., CocaCola Enterprises Inc., SAVVIS Inc May 07 2008 


More From Other Websites
Black Diamond, Invacare, SolarCity and Wal-Mart Stores highlighted as Zacks Bull and Bear of the Day Nov 24 2014
Bear of the Day: Invacare Corp (IVC) Nov 24 2014
Invacare Declares Quarterly Dividend Nov 21 2014
Invacare (IVC) Down to Strong Sell on Dismal Q3 Results Nov 20 2014
Invacare Corporation Announces Executive Retirement Nov 15 2014
INVACARE CORP Files SEC form 8-K, Change in Directors or Principal Officers Nov 14 2014
Mal Mixon to Retire as Executive Chairman of Invacare Corporation at Year-End Nov 14 2014
Mal Mixon to Retire as Executive Chairman of Invacare Corporation at Year-End Nov 14 2014
Invacare Corporation Announces Executive Retirement Nov 14 2014
INVACARE CORP Financials Nov 14 2014
10-Q for Invacare Corp. Nov 09 2014
INVACARE CORP Files SEC form 10-Q, Quarterly Report Nov 06 2014
Invacare (IVC) is Overbought: Is A Drop Coming? Oct 29 2014
Invacare Corporation (IVC) in Focus: Stock Surges 14.5% Oct 27 2014
Invacare (IVC) Stock Upgraded Today at KeyBanc Oct 24 2014
INVACARE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 23 2014
Q3 2014 Invacare Corp Earnings Release - Before Market Open Oct 23 2014
Invacare posts 3Q loss Oct 23 2014
Invacare posts 3Q loss Oct 23 2014
Invacare Corporation Announces Financial Results for the Third Quarter of 2014 Oct 23 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK